Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Biodesix, Inc. (BDSX) vs Insight Molecular Diagnostics Inc. (IMDX)

Biodesix, Inc. and Insight Molecular Diagnostics Inc. are both Diagnostics & Research companies. Biodesix, Inc. is the larger, with a market value of $310.2M against $129.3M — 2.4× the size. Biodesix, Inc. grew revenue faster over the last twelve months: 34.5% against −60.8%. Biodesix, Inc. has the higher net margin (−27.0% vs −2,955.6%) and the lower return on invested capital (−49.6% vs 0.00%). Across the 17 metrics below, Biodesix, Inc. leads on 12 and Insight Molecular Diagnostics Inc. on 5.

Valuation

Metric BDSX IMDX Diagnostics & Research median
P/E n/m n/m 33.95
P/S 2.91 86.26 4.87
P/B 32.77 n/m 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales 3.07 75.74 5.66
Earnings yield (10.89%) (38.01%) (1.75%)
Free cash flow yield (6.81%) (21.52%) (0.13%)

Profitability

Metric BDSX IMDX Diagnostics & Research median
Gross margin 82.50% 48.32% 50.89%
Operating margin (20.02%) (3,011.86%) (8.57%)
Net margin (26.97%) (2,955.63%) (6.37%)
Free cash flow margin (19.82%) (1,856.23%) 0.00%
Return on equity (540.01%) 488.68% (2.92%)
Return on assets (30.33%) (123.46%) (6.71%)
Return on invested capital (49.60%) 0.00% 0.00%

Growth

Metric BDSX IMDX Diagnostics & Research median
Revenue growth (TTM) 34.46% (60.77%) 7.69%
EPS growth (last fiscal year) 29.24% 64.59% —
Revenue growth, 5-year CAGR 14.20% 27.24% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDSX IMDX Diagnostics & Research median
Debt to equity 5.12 (0.04) 0.11
Current ratio 2.85 2.00 2.02
Net debt to EBITDA (1.36) (0.67) 0.78

Dividend

Metric BDSX IMDX Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric BDSX IMDX Diagnostics & Research median
Market cap 310.20m 129.26m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack